{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:25:12Z","timestamp":1793125512548,"version":"4.5.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:00:00Z","timestamp":1614038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["FIS PI13\/0065"],"award-info":[{"award-number":["FIS PI13\/0065"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To assess the potential diagnostic utility of advanced lymphocyte profiling to differentiate between primary Sj\u00f6gren\u2019s Syndrome (pSS) and non-Sj\u00f6gren Sicca syndrome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Distribution of peripheral lymphocyte subpopulations was analysed by flow cytometry in 68 patients with pSS, 26 patients with sicca syndrome and 23 healthy controls. The ability to discriminate between pSS and sicca syndrome was analysed using the area under the curve (AUC) of the receiver operating characteristic curve of the different lymphocyte subsets.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The ratio between na\u00efve\/memory B cell proportions showed an AUC of 0.742 to differentiate pSS and sicca syndrome, with a sensitivity of 76.6% and a specificity of 72% for a cut-off value of 3.4. The ratio of non-switched memory B cells to activated CD4+ T cells percentage (BNSM\/CD4ACT) presented the highest AUC (0.840) with a sensitivity of 83.3% and specificity of 81.7% for a cut-off value &amp;lt;4.1. To differentiate seronegative pSS patients from sicca patients, the BNSM\/CD4ACT ratio exhibited an AUC of 0.742 (sensitivity 75%, specificity 66.7%, cut-off value &amp;lt;4.4), and the number of na\u00efve CD4 T cells had an AUC of 0.821 (sensitivity 76.9%, specificity 88.9%, cut-off value &amp;lt;312\/mm3).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Patients with pSS show a profound imbalance in the distribution of circulating T and B lymphocyte subsets. The ratio BNSM\/CD4ACT is useful to discriminate between pSS and sicca syndrome.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab170","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T12:47:39Z","timestamp":1613998059000},"page":"5647-5658","source":"Crossref","is-referenced-by-count":9,"title":["Utility of lymphocyte phenotype profile to differentiate primary Sj\u00f6gren\u2019s syndrome from sicca syndrome"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6451-8971","authenticated-orcid":false,"given":"Jos\u00e9","family":"Loureiro-Amigo","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Autoimmune Systemic Diseases Unit, Hospital Universitari Vall d\u2019Hebron"},{"name":"Department of Medicine, Faculty of Medicine, Universitat Aut\u00f2noma de Barcelona (UAB)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Palacio-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Haematology Department, Flow Cytometry Unit, Hospital Universitari Vall d\u2019Hebron"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Mart\u00ednez-Gallo","sequence":"additional","affiliation":[{"name":"Immunology Department, Hospital Universitari Vall d'Hebron, Universitat Aut\u00f2noma de Barcelona (UAB), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Mart\u00ednez-Valle","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Autoimmune Systemic Diseases Unit, Hospital Universitari Vall d\u2019Hebron"},{"name":"Department of Medicine, Faculty of Medicine, Universitat Aut\u00f2noma de Barcelona (UAB)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ramentol-Sintas","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Autoimmune Systemic Diseases Unit, Hospital Universitari Vall d\u2019Hebron"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roser","family":"Sol\u00e1ns-Laqu\u00e9","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Autoimmune Systemic Diseases Unit, Hospital Universitari Vall d\u2019Hebron"},{"name":"Department of Medicine, Faculty of Medicine, Universitat Aut\u00f2noma de Barcelona (UAB)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"key":"2021121823175885400_keab170-B1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sj\u00f6gren\u2019s syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"2021121823175885400_keab170-B2","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021121823175885400_keab170-B3","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/rheumatology\/kep141","article-title":"Health-related quality of life, employment and disability in patients with Sjogren\u2019s syndrome","volume":"48","author":"Meijer","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"2021121823175885400_keab170-B4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","article-title":"Systemic activity and mortality in primary Sj\u00f6gren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients","volume":"75","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021121823175885400_keab170-B5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary Sj\u00f6gren\u2019s syndrome","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"2021121823175885400_keab170-B6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","article-title":"Systemic involvement in primary Sj\u00f6gren\u2019s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 spanish patients (GEAS-SS registry)","volume":"53","author":"Ramos-Casals","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2021121823175885400_keab170-B7","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"key":"2021121823175885400_keab170-B8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bjh.13192","article-title":"Sj\u00f6gren Syndrome-associated lymphomas: an update on pathogenesis and management","volume":"168","author":"Nocturne","year":"2015","journal-title":"Br J Haematol"},{"key":"2021121823175885400_keab170-B9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.semarthrit.2011.04.006","article-title":"Risk, predictors, and clinical characteristics of lymphoma development in primary Sj\u00f6gren\u2019s syndrome","volume":"41","author":"Solans-Laqu\u00e9","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"2021121823175885400_keab170-B10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2017.03.007","article-title":"Insight into pathogenesis of Sj\u00f6gren\u2019s syndrome: dissection on autoimmune infiltrates and epithelial cells","volume":"182","author":"Goules","year":"2017","journal-title":"Clin Immunol"},{"key":"2021121823175885400_keab170-B11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary Sj\u00f6gren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2021121823175885400_keab170-B12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2021121823175885400_keab170-B13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/eji.201948129","article-title":"Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sj\u00f6grens syndrome","volume":"50","author":"van der Kroef","year":"2020","journal-title":"Eur J Immunol"},{"key":"2021121823175885400_keab170-B14","doi-asserted-by":"crossref","first-page":"854706","DOI":"10.1155\/2015\/854706","article-title":"Distribution of peripheral lymphocyte populations in primary Sj\u00f6gren\u2019s syndrome patients","volume":"2015","author":"Sudzius","year":"2015","journal-title":"J Immunol Res"},{"key":"2021121823175885400_keab170-B15","first-page":"726","article-title":"CD4+ T-lymphocytopenia\u2014a frequent finding in anti-SSA antibody seropositive patients with primary Sj\u00f6gren\u2019s syndrome","volume":"31","author":"Mandl","year":"2004","journal-title":"J Rheumatol"},{"key":"2021121823175885400_keab170-B16","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jaci.2016.01.024","article-title":"Cytometry by time-of-flight immunophenotyping identifies a blood Sj\u00f6gren\u2019s signature correlating with disease activity and glandular inflammation","volume":"137","author":"Mingueneau","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2021121823175885400_keab170-B17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/sji.12622","article-title":"Patients with primary Sj\u00f6gren\u2019s syndrome have alterations in absolute quantities of specific peripheral leucocyte populations","volume":"86","author":"Davies","year":"2017","journal-title":"Scand J Immunol"},{"key":"2021121823175885400_keab170-B18","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/art.38734","article-title":"Primary Sj\u00f6gren\u2019s syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells","volume":"66","author":"Roberts","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2021121823175885400_keab170-B19","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/art.10445","article-title":"Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sj\u00f6gren\u2019s syndrome","volume":"46","author":"Hansen","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2021121823175885400_keab170-B20","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.4049\/jimmunol.167.7.3610","article-title":"Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren\u2019s syndrome","volume":"167","author":"Bohnhorst","year":"2001","journal-title":"J Immunol"},{"key":"2021121823175885400_keab170-B21","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/art.20276","article-title":"Abnormalities in peripheral B cell memory of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"50","author":"Hansen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2021121823175885400_keab170-B22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cei.12703","article-title":"A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjogren\u2019s syndrome and systemic lupus erythematosus","volume":"183","author":"Szab\u00f3","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"2021121823175885400_keab170-B23","doi-asserted-by":"crossref","first-page":"e114575","DOI":"10.1371\/journal.pone.0114575","article-title":"Accumulation of self-reactive naive and memory B cell reveals sequential defects in B cell tolerance checkpoints in Sjogren\u2019s syndrome","volume":"9","author":"Corsiero","year":"2014","journal-title":"PLoS One"},{"key":"2021121823175885400_keab170-B24","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/ar4442","article-title":"Diagnostic accuracy of blood B-cell subset profiling and autoimmunity markers in Sj\u00f6gren\u2019s syndrome","volume":"16","author":"Cornec","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2021121823175885400_keab170-B25","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/ard.2008.096172","article-title":"Is the blood B-cell subset profile diagnostic for Sjogren syndrome?","volume":"68","author":"Binard","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021121823175885400_keab170-B26","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00296-018-4018-0","article-title":"Association between memory B-cells and clinical and immunological features of primary Sj\u00f6gren\u2019s syndrome and Sicca patients","volume":"38","author":"Barcelos","year":"2018","journal-title":"Rheumatol Int"},{"key":"2021121823175885400_keab170-B27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"2021121823175885400_keab170-B28","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2021121823175885400_keab170-B29","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1136\/annrheumdis-2015-208504","article-title":"Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies","volume":"75","author":"Seror","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021121823175885400_keab170-B30","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/ard.2010.143743","article-title":"EULAR Sj\u00f6gren\u2019s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sj\u00f6gren\u2019s syndrome","volume":"70","author":"Seror","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2021121823175885400_keab170-B31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the Human Immunology Project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2021121823175885400_keab170-B32","first-page":"307","article-title":"Abnormal expression of apoptosis-related antigens, Fas and bcl-2, on circulating T-lymphocytes subsets in primary Sjogren\u2019s syndrome","volume":"13","author":"Ichikawa","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"2021121823175885400_keab170-B33","first-page":"609","article-title":"CD4+ T-lymphocytopenia without HIV infection: increased prevalence among patients with primary Sj\u00f6gren\u2019s syndrome","volume":"13","author":"Kirtava","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"2021121823175885400_keab170-B34","first-page":"125","article-title":"CD4 cytopenia and occasional expansion of CD4+CD8+ lymphocytes in Sj\u00f6gren\u2019s syndrome","volume":"14","author":"Ferraccioli","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"2021121823175885400_keab170-B35","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/1529-0131(199908)42:8<1673::AID-ANR16>3.0.CO;2-1","article-title":"Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"42","author":"Zeher","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2021121823175885400_keab170-B36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/sarh.2003.50019","article-title":"Apoptosis and Sj\u00f6gren syndrome","volume":"33","author":"Manganelli","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"2021121823175885400_keab170-B37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","article-title":"Characteristics of the minor salivary gland infiltrates in Sj\u00f6gren\u2019s syndrome","volume":"34","author":"Christodoulou","year":"2010","journal-title":"J Autoimmun"},{"key":"2021121823175885400_keab170-B38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2012.01.002","article-title":"Pathogenesis of Sj\u00f6gren\u2019s syndrome: what we know and what we should learn","volume":"39","author":"Tzioufas","year":"2012","journal-title":"J Autoimmun"},{"key":"2021121823175885400_keab170-B39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaut.2012.05.019","article-title":"The T cell in Sjogren\u2019s syndrome: force majeure, not spectateur","volume":"39","author":"Singh","year":"2012","journal-title":"J Autoimmun"},{"key":"2021121823175885400_keab170-B40","doi-asserted-by":"crossref","first-page":"243723","DOI":"10.1155\/2015\/243723","article-title":"T regulatory and T helper 17 cells in primary Sj\u00f6gren\u2019s syndrome: facts and perspectives","volume":"2015","author":"Alunno","year":"2015","journal-title":"Mediators Inflamm"},{"key":"2021121823175885400_keab170-B41","doi-asserted-by":"crossref","first-page":"307453","DOI":"10.1155\/2015\/307453","article-title":"The clinical relevance of IL-17-producing CD4+CD161+ cell and its subpopulations in primary Sj\u00f6gren\u2019s syndrome","volume":"2015","author":"Li","year":"2015","journal-title":"J Immunol Res"},{"key":"2021121823175885400_keab170-B42","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/art.21129","article-title":"Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"52","author":"Hansen","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2021121823175885400_keab170-B43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/clim.2002.5199","article-title":"Abnormal B cell differentiation in primary Sj\u00f6gren\u2019s syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with serum IgG concentration","volume":"103","author":"Bohnhorst","year":"2002","journal-title":"Clin Immunol"},{"key":"2021121823175885400_keab170-B44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10067-017-3877-1","article-title":"Altered frequencies of memory B cells in new-onset systemic lupus erythematosus patients","volume":"37","author":"Zhu","year":"2018","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab170\/36836417\/keab170.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/12\/5647\/41820452\/keab170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/12\/5647\/41820452\/keab170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T23:25:24Z","timestamp":1639869924000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/12\/5647\/6146924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,2,23]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab170","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,2,23]]}}}